Brand or Proprietary Name Safety Research
Consults and Rebuttals
Failure Mode and Effects Analysis
Name Safety Reports / Submission
Nonproprietary (USAN / INN) Name Research
Product Labeling, Packaging and Trade Dress Research
Promotional / Advertising Research
Regulatory / Safety Review of Container and Carton Labels and Packaging
Risk Management Plans
USAN / INN / STEM / CLASS Name Development
The Drug Safety Institute (DSI), a subsidiary of Brand Institute, was founded in 2004. DSI is dedicated to improving the safe use of Pharmaceuticals by providing a global, state-of-the-art, research model for proprietary (brand and line extension) and nonproprietary (USAN/INN) nomenclature research. In addition, DSI offers a medication error prevention analysis associated with labeling of pharmaceuticals, biological products and medical devices. DSI also offers various risk management strategies to our clients.
At DSI our plan is to make the Brand Institute methodology for proprietary and nonproprietary name safety testing reflective of the FDA and other regulatory agencies review processes.